source
- Saudi Arabia pushes ahead with biotech hub despite regional instabilitySaudi Arabia is constructing a regulatory framework, partnership networks and intellectual property structures to nurture a biotech ecosystem, even as regional political tensions persist. Experts…
- BridgeBio eyes first FDA approval for limb-girdle muscular dystrophy therapyBridgeBio Pharma is preparing for a potential launch of its experimental drug BBP-418 aimed at treating limb-girdle muscular dystrophy type 2I/R9, pending FDA decision. The agency has set a review…